S&P 500 rises as health care, tech gain to overshadow Fed independence concerns
Susan Wiseman, the General Counsel of Braze , Inc. (NASDAQ:BRZE), a $4.3 billion market cap company, recently sold a significant portion of her holdings. According to InvestingPro data, Braze maintains strong financial health with more cash than debt on its balance sheet. The Form 4 filing with the Securities and Exchange Commission shows Wiseman sold a total of 7,411 shares of Class A common stock over two days, amounting to a total transaction value of $299,717.
On February 18, Wiseman sold 3,925 shares at an average price of $40.82 each, totaling $160,218. The transaction was part of a non-discretionary sell-to-cover program to meet tax obligations related to her restricted stock units.
Following this, on February 20, she sold an additional 3,486 shares. This sale included two separate transactions: 1,931 shares sold at an average price of $39.58, and 1,555 shares at an average price of $40.56. These transactions were conducted under a Rule 10b5-1 trading plan.
After these sales, Wiseman retains ownership of 182,109 shares of Braze, including 68,355 shares represented by restricted stock units. The company has demonstrated strong revenue growth of 28% in the last twelve months, according to InvestingPro, which offers comprehensive analysis and additional insights through its Pro Research Report, available for over 1,400 US stocks.
In other recent news, Braze Inc. has been the focus of multiple analyst reports following its recent financial developments. JMP Securities has maintained its Market Outperform rating with a price target of $68, highlighting Braze’s record bookings for the fourth fiscal quarter of 2025 and the expectation of strong revenue and billings. Raymond (NSE:RYMD) James also reiterated its Outperform rating with a $48 target, noting management changes and Braze’s market initiatives aimed at expanding beyond its current run-rate. Meanwhile, Needham adjusted its price target from $70 to $50, retaining a Buy rating despite Braze’s smaller-than-expected revenue outperformance in the third quarter. The firm pointed to Braze’s robust net revenue retention rate as a positive indicator.
Piper Sandler expressed optimism by raising its price target from $44 to $48, maintaining an Overweight rating due to Braze’s solid third-quarter results and growth in subscription revenue. DA Davidson, while reducing its price target from $55 to $50, continued to support Braze with a Buy rating, noting positive trends and stabilization in Dollar-Based Net Retention. The company’s strategic management and non-GAAP net income performance were highlighted as key factors in its outlook. These recent developments reflect a complex landscape for Braze, with analysts weighing in on its financial health and strategic direction.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.